(CLFD) Clearfield - Overview
Sector: Technology | Industry: Communication Equipment | Exchange: NASDAQ (USA) | Market Cap: 566m USD | Total Return: 14.2% in 12m
Avg Turnover: 9.55M
Qual. Beats: 0
Rev. Trend: -87.5%
Qual. Beats: 0
Warnings
P/E ratio 181.2
Fakeout
Tailwinds
No distinct edge detected
Clearfield, Inc. specializes in the design and manufacture of fiber management and protection solutions used to deploy high-speed broadband networks. Its product portfolio includes the FieldSmart management platform, WaveSmart optical components, and FieldShield fiber pathways, which collectively facilitate fiber-to-the-premise (FTTP) and fiber-to-the-cell-site installations. The company serves a diverse client base ranging from national telecommunications carriers to community broadband providers and large enterprises.
The business model focuses on modularity, allowing service providers to scale fiber infrastructure incrementally as subscriber demand grows. This plug-and-play approach aims to reduce the labor costs and specialized expertise typically required for complex fiber splicing and network builds. The industry is currently influenced by significant federal infrastructure funding aimed at expanding high-speed internet access to rural and underserved regions.
To better understand how these infrastructure trends impact long-term valuation, you may want to examine the comprehensive data available on ValueRay. Clearfield operates primarily through a direct sales force and authorized distributors to reach both domestic and international markets.
- Federal BEAD program funding accelerates rural fiber deployment and infrastructure demand
- Excess channel inventory levels pressure short-term revenue and gross margin recovery
- Rural broadband service provider capital expenditure cycles dictate long-term organic growth
- Fiber-to-the-Home market expansion drives demand for FieldSmart and WaveSmart product lines
- Domestic manufacturing capacity utilization impacts operational leverage and profitability metrics
| Net Income: -8.61m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.34 > 1.0 |
| NWC/Revenue: 110.3% < 20% (prev 98.63%; Δ 11.71% < -1%) |
| CFO/TA 0.07 > 3% & CFO 18.1m > Net Income -8.61m |
| Net Debt (-80.1m) to EBITDA (7.54m): -10.63 < 3 |
| Current Ratio: 12.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (13.7m) vs 12m ago -3.01% < -2% |
| Gross Margin: 37.23% > 18% (prev 0.25%; Δ 3.70k% > 0.5%) |
| Asset Turnover: 47.43% > 50% (prev 57.33%; Δ -9.90% > 0%) |
| Interest Coverage Ratio: 5.08 > 6 (EBITDA TTM 7.54m / Interest Expense TTM 381k) |
| A: 0.57 (Total Current Assets 163.0m - Total Current Liabilities 12.7m) / Total Assets 263.5m |
| B: 0.40 (Retained Earnings 105.8m / Total Assets 263.5m) |
| C: 0.01 (EBIT TTM 1.94m / Avg Total Assets 287.2m) |
| D: 5.10 (Book Value of Equity 105.8m / Total Liabilities 20.7m) |
| Altman-Z'' = 10.45 = AAA |
| DSRI: 1.13 (Receivables 20.9m/24.2m, Revenue 136.2m/178.2m) |
| GMI: 0.66 (GM 37.23% / 24.54%) |
| AQI: 1.54 (AQ_t 0.31 / AQ_t-1 0.20) |
| SGI: 0.76 (Revenue 136.2m / 178.2m) |
| TATA: -0.10 (NI -8.61m - CFO 18.1m) / TA 263.5m) |
| Beneish M = -3.18 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 42.78 with a total of 176,219 shares traded.
Over the past week, the price has changed by +0.53%,
over one month by +43.99%,
over three months by +38.30% and
over the past year by +14.18%.
Clearfield has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy CLFD.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 43.8 | 2.3% |
P/E Forward = 50.2513
P/S = 3.8121
P/B = 2.4217
Revenue TTM = 136.2m USD
EBIT TTM = 1.94m USD
EBITDA TTM = 7.54m USD
Long Term Debt = 8.05m USD (estimated: total debt 10.9m - short term 2.89m)
Short Term Debt = 2.89m USD (from shortTermDebt, last quarter)
Debt = 10.9m USD (from shortLongTermDebtTotal, last quarter) (leases 10.9m already included)
Net Debt = -80.1m USD (calculated: Debt 10.9m - CCE 91.1m)
Enterprise Value = 486.1m USD (566.3m + Debt 10.9m - CCE 91.1m)
Interest Coverage Ratio = 5.08 (Ebit TTM 1.94m / Interest Expense TTM 381k)
EV/FCF = 30.21x (Enterprise Value 486.1m / FCF TTM 16.1m)
FCF Yield = 3.31% (FCF TTM 16.1m / Enterprise Value 486.1m)
FCF Margin = 11.81% (FCF TTM 16.1m / Revenue TTM 136.2m)
Net Margin = -6.32% (Net Income TTM -8.61m / Revenue TTM 136.2m)
Gross Margin = 37.23% ((Revenue TTM 136.2m - Cost of Revenue TTM 85.5m) / Revenue TTM)
Gross Margin QoQ = 32.45% (prev 33.16%)
Tobins Q-Ratio = 1.84 (Enterprise Value 486.1m / Total Assets 263.5m)
Interest Expense / Debt = 3.48% (Interest Expense 381k / Debt 10.9m)
Taxrate = 27.20% (2.36m / 8.67m)
NOPAT = 1.41m (EBIT 1.94m * (1 - 27.20%))
Current Ratio = 12.84 (Total Current Assets 163.0m / Total Current Liabilities 12.7m)
Debt / Equity = 0.05 (Debt 10.9m / totalStockholderEquity, last quarter 242.8m)
Debt / EBITDA = -10.63 (Net Debt -80.1m / EBITDA 7.54m)
Debt / FCF = -4.98 (Net Debt -80.1m / FCF TTM 16.1m)
Total Stockholder Equity = 253.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.00% (Net Income -8.61m / Total Assets 263.5m)
RoE = -3.40% (Net Income TTM -8.61m / Total Stockholder Equity 253.3m)
RoCE = 0.74% (EBIT 1.94m / Capital Employed (Equity 253.3m + L.T.Debt 8.05m))
RoIC = 0.87% (NOPAT 1.41m / Invested Capital 162.7m)
WACC = 11.76% (E(566.3m)/V(577.2m) * Re(11.94%) + D(10.9m)/V(577.2m) * Rd(3.48%) * (1-Tc(0.27)))
Discount Rate = 11.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -4.64%
[DCF] Terminal Value 62.54% ; FCFF base≈16.8m ; Y1≈15.4m ; Y5≈13.7m
[DCF] Fair Price = 16.10 (EV 138.7m - Net Debt -80.1m = Equity 218.8m / Shares 13.6m; r=11.76% [WACC]; 5y FCF grow -10.22% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.67 | # QB: 0
Revenue Correlation: -87.52 | Revenue CAGR: -21.16% | SUE: 0.06 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.24 | Chg30d=+4.26% | Revisions=-20% | Analysts=2
EPS current Year (2026-09-30): EPS=0.70 | Chg30d=+0.00% | Revisions=+20% | GrowthEPS=+55.6% | GrowthRev=+9.9%
EPS next Year (2027-09-30): EPS=1.45 | Chg30d=-17.14% | Revisions=+20% | GrowthEPS=+107.1% | GrowthRev=+21.5%
[Analyst] Revisions Ratio: -20%